Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract: From Surgery to Targeted Therapies:...

— —

Eric Raymond Sandrine Faivre

Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract

From Surgery to Targeted Therapies: A Multidisciplinary Approach

Eric Raymond, Sandrine Faivre, Philippe Ruszniewski

$130.95 $105.07

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Springer Editions
23 August 2016

Radiotherapy; Endocrinology; Gastroenterology; Surgical oncology

This book pursues a multidisciplinary approach, presenting chapters with updated information on various aspects of treatment for patients with neuroendocrine tumors. Authors have been selected from expert centers in Europe and the United States. The goal of this book is to comprehensively summarize recent data and provide inspiring ideas to optimize the care of patients with neuroendocrine tumors.

Neuroendocrine tumors are fascinating multifaceted diseases that can primarily localize in many organs with various presentations. These tumors are rare but their increasing incidence renders likely that physicians caring for cancers may have either already faced or may be certainly exposed to diagnose and/or treat a patient with neuroendocrine tumors. Over the last years, novel therapeutic options have emerged for neuroendocrine tumors, profoundly challenging practices that had previously been the standards for decades. These include - but are not limited to - somatostatin analogues, targeted therapies such as tyrosine kinase and mTOR inhibitors, antiangiogenic compounds, but also peptide-receptor targeted therapy or radioembolization. This changing field has generated novel treatment algorithms to guide medical decisions. To better understand and handle the multidisciplinary approaches that are required for optimizing the care of neuroendocrine tumor patients, physicians are now looking for references from experts and comprehensive reviews summarizing current knowledge on treatments for patients with neuroendocrine tumors.

Edited by: Eric Raymond, Sandrine Faivre, Philippe Ruszniewski
Imprint: Springer Editions
Country of Publication: France
Edition: Softcover reprint of the original 1st ed. 2014
Dimensions: Height: 235mm, Width: 155mm, Spine: 13mm
Weight: 519g
ISBN: 9782817805542
ISBN 10: 2817805542
Pages: 236
Publication Date: 23 August 2016
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Scintigraphy in Endocrine Tumors of the Gut.- Profiling the PI3K/Akt/Mtor Intracellular Pathway in Neuroendocrine Tumors.- Relevance of Angiogenesis in Neuroendocrine Tumors.- Advances with Somatostatin Analogues in Neuroendocrine Tumors: The Promise of Radionuclides in Neuroendocrine Tumors.- Streptozotocin-Based Chemotherapy is not History in Neuroendocrine Tumors.- Place of Surgical Resection in the Treatment Strategy in Neuroendocrine Tumors.- Endoscopic Resection of Gastrointestinal Neuroendocrine Tumors.- Liver-Targeting Therapies in Neuroendocrine Tumors.- Inhibition of Mtor in Neuroendocrine Tumors of the Digestive Tract.- Sunitinib in Pancreatic Neuroendocrine Tumors.- Clinical Management of Targeted Therapies in Neuroendocrine Tumors.- Imaging Tumor Response to Angiogenesis Inhibitors in Neuroendocrine Tumors.- Resistance to Targeted Therapies in Neuroendocrine Tumors.- New Anticancer Agents in Neuroendocrine Tumors.- Management of Symptoms and Patient Related Outcome Optimization in Neuroendocrine Tumors of the Digestive Tract.- Clinical Approaches of Emergencies in NET.

Co-editors: Prof. Eric Raymond is Head of Department of Medical Oncology at Bichat - Beaujon University Hospitals (Clichy - Paris, France). He is member of the ENETS' Executive Committee (European neuroendocrine tumors society) and active editorial board member of Targeted Oncology journal. Prof. Sandrine Faivre is deputy head Department of Medical Oncology at Bichat - Beaujon University Hospitals ((Clichy - Paris, France). She is editorial board member of Targeted Oncology journal. Prof. Philippe Ruszniewski is Head of Department of Gastroenterology and pancreatology at Beaujon University Hospitals (Clichy - Paris, France). He is vice-Chairman of the ENETS' Executive Committee.

Reviews for Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract: From Surgery to Targeted Therapies: A Multidisciplinary Approach

This is a comprehensive treatise on the multidisciplinary management of neuroendocrine tumours (NETs). It has been written primarily for medical oncologists and gastroenterologists with an interest in NETs. ... This book aims to provide current knowledge on various aspects of treatment of patients with NET that is easily understandable by the readers. The authors have succeeded in providing a source of updated information for physicians involved in caring for such patients. (Sujoy Pal, The National Medical Journal of India, Vol. 28 (2), 2015) This is a high yield, contemporary summary of the treatment of pancreatic and gastrointestinal neuroendocrine tumors (P-NETS, GI-NETS). ... This book is ideal for medical oncologists, endocrinologists, radiation oncologists, and surgeons who care for these patients, both attending and fellow level practitioners. ... This is a unique book - there are not many like it in the field. It is a high-yield book that does not replicate other publications. (James J. Mezhir, Doody's Book Reviews, September, 2014)